CH
抗体药类似物
Research Grade Tregalizumab
All
  • CatalogTD-HF998036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBT-061, hB-F5, hBF5(H37L_L4M), CAS: 1207446-68-1
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Tregalizumab


Catalog No. HF998036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P01730
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names BT-061, hB-F5, hBF5(H37L_L4M), CAS: 1207446-68-1
Background Tregalizumab is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs) in vitro. Tregalizumab can be used in the research of autoimmune diseases (resulting from insufficient Treg activity) and allergies.
Note For research use only. Not suitable for clinical or therapeutic use.